EK
Elekta AB (publ)
EKTAY · OTC
$5.24 +0.91% (+$0.05)
1M -11.51%
Market Cap 19.7B kr
P/E Ratio -
Div. Yield 4.90%
ROE 4.68%
Bulios Fair Price
$7.76
48.2% upside
Current Price
$5.24
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EKTAY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
81 /100
Cheap EV/EBITDA 12.81x
P/S 1.20x
P/B 2.61x
Growth
43 /100
Stable Rev. growth 0.96%
FCF growth 79.09%
Book val. growth 10.12%
Profitability
47 /100
Moderate Gross margin 38.65%
Net margin 2.21%
Op. margin 6.24%
Quality
8 /100
Poor ROIC 39.55%
ROE 4.68%
ROA 1.37%
Debt
49 /100
Moderate Debt/Equity 0.90x
Current ratio 0.86x
Int. coverage 3.73x
Stability
50 /100
Moderate Beta 1.08x
Rev. volatility 8.22%
EPS volatility 175.76%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EKTAY
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Jakob Just-Bomholt
Employees
4,102
Headquarters
Stockholm
Upcoming events
25 NOV
Earnings
Upcoming earnings report